Entering text into the input field will update the search result below

OvaScience's AUGMENT delivers 53% pregnancy rate in difficult-to-treat women

  • Fertility specialists presented data today from their experiences with OvaSciences's (OVAS-OLD +2.3%) AUGMENT fertility treatment at the Society for Reproductive Investigation 62nd Annual Scientific Meeting.
  • Robert Casper, M.D., Medical Director of TCART Fertility Partners, Toronto, Canada, reported a 53% clinical pregnancy rate (n=9/17) in women who received AUGMENT treatment after failing one to three previous in vitro fertilization (IVF) cycles, often with poor embryo quality.
  • Pregnancy rates across IVF clinics using AUGMENT range from 25 - 53%.
  • The company will host a conference call tomorrow morning at 10:00 am ET to discuss the results.
  • Previously: OvaScience schedules webcast to discuss AUGMENT fertility treatment (March 25)

Recommended For You

Related Stocks

SymbolLast Price% Chg
OVAS-OLD--
OvaScience, Inc.